Article Information
History
- December 26, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Rana Abdelnabi1,
- Caroline S. Foo1,
- Xin Zhang1,
- Viktor Lemmens1,2,
- Piet Maes3,4,
- Bram Slechten5,
- Joren Raymenants6,
- Emmanuel André5,6,
- Birgit Weynand7,
- Kai Dallemier1,2,8 and
- Johan Neyts1,2,8,*
- 1KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000 Leuven, Belgium
- 2Molecular Vaccinology and Vaccine Discovery
- 3Laboratory of Clinical and Epidemiological Virology, Rega Institute, KU Leuven, Department of Microbiology, Immunology and Transplantation, 3000, Leuven, Belgium
- 4Zoonotic Infectious Diseases Unit, Leuven, Belgium
- 5Department of Laboratory Medicine, UZ Leuven Hospital, 3000 Leuven, Belgium
- 6Laboratory of Clinical Bacteriology and Mycology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3000 Leuven, Belgium
- 7KU Leuven Department of Imaging and Pathology, Translational Cell and Tissue Research, B-3000 Leuven, Belgium; Division of Translational Cell and Tissue Research
- 8Global Virus Network, GVN
- ↵*To whom correspondence may be addressed. Email: johan.neyts{at}kuleuven.be.
Posted December 26, 2021.
The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters
